Mika Health, AstraZeneca, and Daiichi Sankyo Launch "UNITE" Initiative to Enhance Breast Cancer Treatment Experience

Mika Health, a global digital therapeutics developer specializing in meeting the needs of cancer patients, in collaboration with AstraZenecaand Daiichi S...

June 19, 2024 | Wednesday | News
Macomics and IOR Collaborate to Advance Prostate Cancer Research with Novel Macrophage-Targeted Therapies

Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on myeloi...

June 19, 2024 | Wednesday | News
Roche's Digital Pathology System Receives FDA Clearance for Clinical Diagnosis

The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now cl...

June 18, 2024 | Tuesday | News
Junshi Biosciences' Toripalimab Approved in China for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

June 18, 2024 | Tuesday | News
LIXTE Biotechnology Announces Clinical Trial Collaboration with Roche and NKI for MSI Low Metastatic Colon Cancer

LIXTE Biotechnology Holdings, Inc.  a clinical stage pharmaceutical company, today announced a collaboration with Roche and the Netherlands Cancer I...

June 17, 2024 | Monday | News
Biosplice Therapeutics and Novo Nordisk Partner to Develop Innovative Diabetes Treatments Targeting DYRK Inhibition

  Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...

June 13, 2024 | Thursday | News
Wyss Center and Dandelion Science Announce Pioneering AI Neuromodulation Partnership

The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science are excited to announce a partnership focused on a cutting-edge generat...

June 12, 2024 | Wednesday | News
Global Cancer Cases Set to Surge to 32 Million Annually by 2050, with Dramatic Increases in Low-Income Countries

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...

June 11, 2024 | Tuesday | Reports
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, a...

June 11, 2024 | Tuesday | News
FDA Grants Emergency Use Authorization for Roche's Rapid PCR Test for SARS-CoV-2, Influenza A/B, and RSV

The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and different...

June 10, 2024 | Monday | News
QIAGEN Launches Enhanced QIAstat-Dx Respiratory Panel in Malaysia, Now Detects 23 Pathogens Including Chlamydophila pneumoniae

The CE-IVD marked QIAstat-Dx Respiratory SARS-CoV-2 Panel is available in Malaysia  expanded to 23 pathogens, now includes Chlamydophila pneumoniae&nb...

June 05, 2024 | Wednesday | News
Pfizer's ADCETRIS Combination Therapy Shows Remarkable 37% Reduction in Risk of Death in Phase 3 ECHELON-3 Study

Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy ...

June 03, 2024 | Monday | News
Thermo Fisher Scientific Advances Research with New Analytical Instruments and Workflow Capabilities for Precision Medicine

  Thermo Fisher Scientific, a global leader in scientific research solutions, has introduced cutting-edge solutions aimed at enhancing research wor...

June 03, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close